ARCHIVES

In a letter, ASCO reaffirms its views on oncology consolidation at FDA.

This article is from The Cancer Letter archive.

Vol. 30 No. 28 | July 9, 2004

Download PDF Visit The Full Archive

Related Articles

BRCA2 Carriers Reduced BC Risk By Prophylactic Surgery

June 30, 2006

Combine Phase 1-2, Abolish DRG, Slash Indirect Costs, Garb Tells Congress

November 27, 1981

NCI Approved CTEP Trials For the Month of August

August 31, 2012

ODAC Votes For Approval Of PegIntron For Melanoma, Votrient For Renal Cancer

October 9, 2009

Drug Development: FDA Grants Breakthrough Therapy Designation to CTL019 In ALL

July 11, 2014

Patient Harm—Including One Death—Cited As Faculty Challenges MD Anderson Leadership

September 20, 2013